Spelling suggestions: "subject:"vrystelling"" "subject:"vrystellings""
1 |
Formulation, characterisation and topical delivery of salicylic acid containing whey-protein stabilised emulsions / Johann CombrinkCombrinck, Johann January 2014 (has links)
Emulsions are widely used as topical formulations in the pharmaceutical and cosmetic industry.
They are thermodynamically unstable and require emulsifiers to stabilize them physically. A
literature survey has revealed that emulsifiers could have an effect on topical delivery.
Therefore, the overall aim of this research project was to investigate and to understand the
various effects of biopolymers, chosen for this study as emulsifiers, on the release and the
topical delivery of an active ingredient from emulsion-based delivery systems. Emulsions were
stabilized by either whey protein alone or in combination with chitosan or carrageenan. Salicylic
acid was chosen as a model drug. Furthermore, the emulsions were prepared at three different
pH values (pH 4, 5 and 6) in order to introduce different charges to the polymeric emulsifiers
and subsequently determine the effect of pH on release as well as on dermal and transdermal
delivery. Emulsion characteristics, such as droplet size, zeta potential, viscosity and stability
against creaming and coalescence were ascertained. In addition, turbidity was determined to
evaluate the degree of insoluble complex formation in the aqueous phase of the emulsions. A
high pressure liquid chromatographic (HPLC) method was validated for the quantitative
determination of salicylic acid in the release, skin and transdermal perfusate samples. Nine
emulsions were formulated, utilizing the layer-by-layer (LbL) self-assembly technique, from
which the release of salicylic acid was determined. These release studies were conducted,
utilizing nitrocellulose membranes (0.2 μm pore size) with the use of Franz-type diffusion cells in
four replicates per formulation over a time period of 8 hours. Based on the emulsion
characterization and release data, six formulations, including the oil solution, were chosen to
determine dermal and transdermal delivery of salicylic acid. During the diffusion studies, the
effect of different pH (whey protein pH 4.00, 5.00 and 6.00), different polymers and different
polymer combinations were investigated. These diffusion studies were conducted with the use
of dermatomed (thickness ~400 μm), human abdominal skin and Franz-type diffusion cells over
a period of 24 hours. The characterization of the emulsions revealed no significant differences
in the droplet size and viscosity between the various formulations. All emulsions showed
stability towards coalescence over a time period of 7 days; however, not all the emulsions
showed stability towards creaming and flocculation. The results of the release studies indicated
that an increase in emulsion droplet charge could have a negative effect on the release of
salicylic acid from these formulations. In contrast, positively charged emulsion droplets could
enhance the dermal and transdermal delivery of salicylic acid from emulsions. It was
hypothesized that electrostatic complex formation between the emulsifier and salicylic acid
could affect the release, whereas electrostatic interaction between emulsion droplets and skin
could influence dermal/transdermal delivery of the active. Furthermore, the degree of ionization
of salicylic acid played an important role in the dermal and transdermal delivery of salicylic acid
from the various emulsions. / MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2014
|
2 |
Formulation, characterisation and topical delivery of salicylic acid containing whey-protein stabilised emulsions / Johann CombrinkCombrinck, Johann January 2014 (has links)
Emulsions are widely used as topical formulations in the pharmaceutical and cosmetic industry.
They are thermodynamically unstable and require emulsifiers to stabilize them physically. A
literature survey has revealed that emulsifiers could have an effect on topical delivery.
Therefore, the overall aim of this research project was to investigate and to understand the
various effects of biopolymers, chosen for this study as emulsifiers, on the release and the
topical delivery of an active ingredient from emulsion-based delivery systems. Emulsions were
stabilized by either whey protein alone or in combination with chitosan or carrageenan. Salicylic
acid was chosen as a model drug. Furthermore, the emulsions were prepared at three different
pH values (pH 4, 5 and 6) in order to introduce different charges to the polymeric emulsifiers
and subsequently determine the effect of pH on release as well as on dermal and transdermal
delivery. Emulsion characteristics, such as droplet size, zeta potential, viscosity and stability
against creaming and coalescence were ascertained. In addition, turbidity was determined to
evaluate the degree of insoluble complex formation in the aqueous phase of the emulsions. A
high pressure liquid chromatographic (HPLC) method was validated for the quantitative
determination of salicylic acid in the release, skin and transdermal perfusate samples. Nine
emulsions were formulated, utilizing the layer-by-layer (LbL) self-assembly technique, from
which the release of salicylic acid was determined. These release studies were conducted,
utilizing nitrocellulose membranes (0.2 μm pore size) with the use of Franz-type diffusion cells in
four replicates per formulation over a time period of 8 hours. Based on the emulsion
characterization and release data, six formulations, including the oil solution, were chosen to
determine dermal and transdermal delivery of salicylic acid. During the diffusion studies, the
effect of different pH (whey protein pH 4.00, 5.00 and 6.00), different polymers and different
polymer combinations were investigated. These diffusion studies were conducted with the use
of dermatomed (thickness ~400 μm), human abdominal skin and Franz-type diffusion cells over
a period of 24 hours. The characterization of the emulsions revealed no significant differences
in the droplet size and viscosity between the various formulations. All emulsions showed
stability towards coalescence over a time period of 7 days; however, not all the emulsions
showed stability towards creaming and flocculation. The results of the release studies indicated
that an increase in emulsion droplet charge could have a negative effect on the release of
salicylic acid from these formulations. In contrast, positively charged emulsion droplets could
enhance the dermal and transdermal delivery of salicylic acid from emulsions. It was
hypothesized that electrostatic complex formation between the emulsifier and salicylic acid
could affect the release, whereas electrostatic interaction between emulsion droplets and skin
could influence dermal/transdermal delivery of the active. Furthermore, the degree of ionization
of salicylic acid played an important role in the dermal and transdermal delivery of salicylic acid
from the various emulsions. / MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2014
|
3 |
Formulation, characterisation and topical application of oil powders from whey protein stabilised emulsions / Magdalena KotzeKotze, Magdalena January 2014 (has links)
The available literature indicates that to date, few research has been performed on oil powders for topical delivery. The aim of this project was to investigate the release characteristics of oil powder formulations, as well as their dermal and transdermal delivery properties.
Whey protein-stabilised emulsions were used to develop oil powders. Whey protein was used alone, or in combination with chitosan or carrageenan. Nine oil powders, with salicylic acid as the active ingredient, were formulated by using the layer-by-layer method. Three different pH values (pH 4, 5 and 6) were used to prepare the formulations, because of the different charges that polymeric emulsifiers may have.
The characteristics of the prepared oil powders were determined, including their droplet sizes, particle size distributions, loss on drying, encapsulation efficiencies, oil leakage and water dispersibility.
Release studies (membrane diffusion studies) were conducted by utilising cellulose acetate membranes (0.2 μm pore size) and Franz-type diffusion cells over a period of eight hours. The release of the active ingredient was determined for all nine powders, their respective template emulsions, as well as their respective oil powders redispersed in water. The release of salicylic acid from the respective redispersed oil powders was then further compared to its release from the template emulsions and from the oil powders.
The effect of pH and different polymer types used in preparing the oil powders, their respective redispersed oil powders and the template emulsions were determined with regards to the release of the active ingredient from all these preparations. The effect of pH and different polymers used was furthermore determined on the oil powders and their respective redispersed oil powders, with regards to their dermal and transdermal deliveries.
Transdermal delivery and skin uptake were investigated on specifically selected powders only, based on the outcomes of the oil powder characterisation and release data. The qualifying formulations were chitosan pH 4, 5 and 6, whey and carrageenan pH 6 oil powders, together with their respective redispersed oil powders in water.
Human abdominal skin was dermatomed (thickness 400 μm) for use in the diffusion studies. Franz-type diffusion cells were used over a period of 24 hours.
The results of the membrane release studies indicated that the oil powders had achieved a significantly higher release than their respective redispersed oil powders. The release of salicylic acid from the redispersed oil powders and from their respective emulsions was similar. The transdermal delivery test outcomes showed that the effect of pH could have been influenced by the degree of ionisation, resulting in a decrease in permeation with increasing ionisation of salicylic acid, in accordance with the pH partition hypothesis. Furthermore, biopolymers, such as chitosan had demonstrated a penetration enhancing effect, which had led to the enhanced dermal and transdermal delivery of salicylic acid. A correlation was also found between the powder particle size and transdermal delivery. / MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2014
|
4 |
Formulation, characterisation and topical application of oil powders from whey protein stabilised emulsions / Magdalena KotzeKotze, Magdalena January 2014 (has links)
The available literature indicates that to date, few research has been performed on oil powders for topical delivery. The aim of this project was to investigate the release characteristics of oil powder formulations, as well as their dermal and transdermal delivery properties.
Whey protein-stabilised emulsions were used to develop oil powders. Whey protein was used alone, or in combination with chitosan or carrageenan. Nine oil powders, with salicylic acid as the active ingredient, were formulated by using the layer-by-layer method. Three different pH values (pH 4, 5 and 6) were used to prepare the formulations, because of the different charges that polymeric emulsifiers may have.
The characteristics of the prepared oil powders were determined, including their droplet sizes, particle size distributions, loss on drying, encapsulation efficiencies, oil leakage and water dispersibility.
Release studies (membrane diffusion studies) were conducted by utilising cellulose acetate membranes (0.2 μm pore size) and Franz-type diffusion cells over a period of eight hours. The release of the active ingredient was determined for all nine powders, their respective template emulsions, as well as their respective oil powders redispersed in water. The release of salicylic acid from the respective redispersed oil powders was then further compared to its release from the template emulsions and from the oil powders.
The effect of pH and different polymer types used in preparing the oil powders, their respective redispersed oil powders and the template emulsions were determined with regards to the release of the active ingredient from all these preparations. The effect of pH and different polymers used was furthermore determined on the oil powders and their respective redispersed oil powders, with regards to their dermal and transdermal deliveries.
Transdermal delivery and skin uptake were investigated on specifically selected powders only, based on the outcomes of the oil powder characterisation and release data. The qualifying formulations were chitosan pH 4, 5 and 6, whey and carrageenan pH 6 oil powders, together with their respective redispersed oil powders in water.
Human abdominal skin was dermatomed (thickness 400 μm) for use in the diffusion studies. Franz-type diffusion cells were used over a period of 24 hours.
The results of the membrane release studies indicated that the oil powders had achieved a significantly higher release than their respective redispersed oil powders. The release of salicylic acid from the redispersed oil powders and from their respective emulsions was similar. The transdermal delivery test outcomes showed that the effect of pH could have been influenced by the degree of ionisation, resulting in a decrease in permeation with increasing ionisation of salicylic acid, in accordance with the pH partition hypothesis. Furthermore, biopolymers, such as chitosan had demonstrated a penetration enhancing effect, which had led to the enhanced dermal and transdermal delivery of salicylic acid. A correlation was also found between the powder particle size and transdermal delivery. / MSc (Pharmaceutics), North-West University, Potchefstroom Campus, 2014
|
Page generated in 0.0626 seconds